-
A newly-published Cochrane review reveals significant gaps in the clinical rating scales used to assess pain in newborn babies, highlighting the urgent need for improved tools and global collaboration.
Despite the critical importance of accurately measuring pain in newborns, the review found that none of the available scales are backed by the high...
11 4月 2025
-
Role: Business Analyst
Location: Remote working (resident in the UK, Germany or Denmark).
Specifications: 6 months Fixed term contract.
Hours: Full-time week (flexible working considered) – 37.5 hours.
Salary: £42,000 per annum.
Application Closing Date: Wednesday 23rd April 2025 (Midnight GMT).
As a Business Analyst, you...
9 4月 2025
-
Cochrane will no longer use the term ‘consumer’ to represent patients and the public, which we previously defined as ‘healthcare consumers’. We have adopted the term ‘patient and public involvement’ to describe research being carried out ‘with’ or ‘by’ members of the public, rather than ‘to’, ‘about’ or ‘for’ them.
Represented groups include...
8 4月 2025
-
Monday 7 April marks World Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to kick off a year-long campaign on maternal and newborn health.
Maternal, newborn, and child health is a major global health priority, and yet in many parts of the world there are still...
7 4月 2025
-
How accurate are Truenat assays for detecting pulmonary tuberculosis and rifampicin resistance?
On World TB Day, we highlight findings from a new review assessing the accuracy of Truenat assays for detecting pulmonary tuberculosis (TB) and rifampicin resistance in adults and adolescents.
TB remains a global health threat, with 10.8 million cases...
20 3月 2025
-
Catherine Spencer OBE, who served as the Cochrane Collaboration’s Chief Executive Officer since 2022, has decided to step down from the role.
Catherine has led Cochrane through transformational change, developing a new strategy for a more evidence-informed world and ensuring the organization is well-placed to deliver it. She has helped to cement...
12 3月 2025
-
March 2025 marks the third anniversary of Cochrane’s commitment to Public Involvement in Health and Social Care Research, a pledge launched in 2022. This commitment underscores Cochrane's ongoing efforts to enhance its practice of public involvement, ensuring that the voices of the users of our evidence are at the heart of health and social care...
11 3月 2025
-
A new Cochrane review has found evidence that music-based therapy may benefit people living with dementia, particularly by improving symptoms of depression.
Dementia is a collective term for progressive degenerative brain syndromes that affect memory, thinking, behaviour and emotion. Alzheimer’s Disease International reported that there were 55...
5 3月 2025
-
We are delighted to announce a new, joint Methods Group between the Cochrane Collaboration, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence (CEE) focusing on artificial intelligence (AI) and automation in evidence synthesis.
The rapidly growing evidence base and the increasing complexity of methods makes ...
28 2月 2025
-
We are pleased to announce that earlier this week, Cochrane’s status as a non-State actor (NSA) in official relations with the World Health Organization (WHO) was renewed at the 156th session of the WHO Executive Board meeting in Geneva.
The Executive Board is composed of 34 technically qualified representatives from different Member States,...
13 2月 2025
-
Honouring Cochrane's Volunteer Translators: Bridging Language Gaps in 2024
Cochrane proudly celebrates the incredible efforts of our volunteer translators in 2024. Their dedication has been instrumental in breaking language barriers and making high-quality health information accessible to communities worldwide.
This year, more than 730 volunteers...
3 2月 2025
-
30 1月 2025
-
New Cochrane Library feature will help Information Specialists and systematic review authors produce trustworthy evidence.
Cochrane has launched a new feature in CENTRAL, our database of reports of clinical trials, to identify and flag publications that have been retracted by the publisher.
Cochrane's policy for managing potentially problematic...
29 1月 2025
-
Cochrane peer reviewers can now feature their peer review activity on their Web of Science profiles thanks to a new collaboration between Cochrane and Clarivate.
Clarivate operates the Web of Science platform, a database that tracks citations, authorship and contributions in peer-reviewed scientific journals. The Web of Science Reviewer...
29 1月 2025
-
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.
GAD affects millions of people worldwide and is characterized by excessive worry about everyday issues. Antidepressants, particularly selective serotonin...
29 1月 2025
-
28 1月 2025
-
A new Cochrane review has found that calorie labelling of food on menus and products leads people to choose slightly fewer calories.
The research team, led by scientists from UCL, Bath Spa University, the University of Cambridge and the University of Oxford, examined evidence from 25 studies on the impact of calorie labelling on food selection and...
16 1月 2025
-
Cochrane’s Future of Evidence Synthesis Programme has brought about some transformational changes
The arrival of 2025 means that we are now wrapping up our Future of Evidence Synthesis Programme, with several projects now closed and a few more due to wrap up by April 2025.
All aspects of the programme were designed to ensure that Cochrane is well...
15 1月 2025
-
9 1月 2025
-
6 1月 2025
A newly-published Cochrane review reveals significant gaps in the clinical rating scales used to assess pain in newborn babies, highlighting the urgent need for improved tools and global collaboration. Despite the critical importance of accurately measuring pain in newborns, the review found that none of the available scales are backed by the high...11 4月 2025
Role: Business Analyst
Cochrane will no longer use the term ‘consumer’ to represent patients and the public, which we previously defined as ‘healthcare consumers’. We have adopted the term ‘patient and public involvement’ to describe research being carried out ‘with’ or ‘by’ members of the public, rather than ‘to’, ‘about’ or ‘for’ them. Represented groups include...8 4月 2025
Monday 7 April marks World Health Day, a day organised by the World Health Organization (WHO) to highlight a particular global health issue. This year, it aims to kick off a year-long campaign on maternal and newborn health. Maternal, newborn, and child health is a major global health priority, and yet in many parts of the world there are still...7 4月 2025
How accurate are Truenat assays for detecting pulmonary tuberculosis and rifampicin resistance? On World TB Day, we highlight findings from a new review assessing the accuracy of Truenat assays for detecting pulmonary tuberculosis (TB) and rifampicin resistance in adults and adolescents. TB remains a global health threat, with 10.8 million cases...20 3月 2025
Catherine Spencer OBE, who served as the Cochrane Collaboration’s Chief Executive Officer since 2022, has decided to step down from the role. Catherine has led Cochrane through transformational change, developing a new strategy for a more evidence-informed world and ensuring the organization is well-placed to deliver it. She has helped to cement...12 3月 2025
March 2025 marks the third anniversary of Cochrane’s commitment to Public Involvement in Health and Social Care Research, a pledge launched in 2022. This commitment underscores Cochrane's ongoing efforts to enhance its practice of public involvement, ensuring that the voices of the users of our evidence are at the heart of health and social care...11 3月 2025
A new Cochrane review has found evidence that music-based therapy may benefit people living with dementia, particularly by improving symptoms of depression. Dementia is a collective term for progressive degenerative brain syndromes that affect memory, thinking, behaviour and emotion. Alzheimer’s Disease International reported that there were 55...5 3月 2025
We are delighted to announce a new, joint Methods Group between the Cochrane Collaboration, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence (CEE) focusing on artificial intelligence (AI) and automation in evidence synthesis. The rapidly growing evidence base and the increasing complexity of methods makes ...28 2月 2025
We are pleased to announce that earlier this week, Cochrane’s status as a non-State actor (NSA) in official relations with the World Health Organization (WHO) was renewed at the 156th session of the WHO Executive Board meeting in Geneva. The Executive Board is composed of 34 technically qualified representatives from different Member States,...13 2月 2025
Honouring Cochrane's Volunteer Translators: Bridging Language Gaps in 2024 Cochrane proudly celebrates the incredible efforts of our volunteer translators in 2024. Their dedication has been instrumental in breaking language barriers and making high-quality health information accessible to communities worldwide. This year, more than 730 volunteers...3 2月 2025
30 1月 2025
New Cochrane Library feature will help Information Specialists and systematic review authors produce trustworthy evidence. Cochrane has launched a new feature in CENTRAL, our database of reports of clinical trials, to identify and flag publications that have been retracted by the publisher. Cochrane's policy for managing potentially problematic...29 1月 2025
Cochrane peer reviewers can now feature their peer review activity on their Web of Science profiles thanks to a new collaboration between Cochrane and Clarivate. Clarivate operates the Web of Science platform, a database that tracks citations, authorship and contributions in peer-reviewed scientific journals. The Web of Science Reviewer...29 1月 2025
A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage. GAD affects millions of people worldwide and is characterized by excessive worry about everyday issues. Antidepressants, particularly selective serotonin...29 1月 2025
A new Cochrane review has found that calorie labelling of food on menus and products leads people to choose slightly fewer calories. The research team, led by scientists from UCL, Bath Spa University, the University of Cambridge and the University of Oxford, examined evidence from 25 studies on the impact of calorie labelling on food selection and...16 1月 2025
Cochrane’s Future of Evidence Synthesis Programme has brought about some transformational changes The arrival of 2025 means that we are now wrapping up our Future of Evidence Synthesis Programme, with several projects now closed and a few more due to wrap up by April 2025. All aspects of the programme were designed to ensure that Cochrane is well...15 1月 2025